References
- Baltadzhieva R, Gurevich T, Korczyn AD. Autonomic impairment in amyotrophic lateral sclerosis. Current Opinion in Neurology & Neurosurgery. 2005; 18: 487–93
- Cluskey S, Ramsden DB. Mechanisms of neurodegeneration in amyotrophic lateral sclerosis. Br Med J. 2001; 54: 386–92
- Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005; 65: 586–90
- Strong, MJ. The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2008;1–16, Epub ahead of print
- Murphy J, Henry R, Lomen-Hoerth C. Establishing subtypes of the continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol. 2007; 64: 330–4
- Pasinelli P, Brown RH. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nature Reviews Neuroscience. 2006; 7: 710–23
- Schymick JC, Talbot K, Traynor BJ. Genetics of sporadic amyotrophic lateral sclerosis. Human Molecular Genetics. 2007; 16: R233–42
- Simmons Z. Management strategies for patients with amyotrophic lateral sclerosis from diagnosis through death. The Neurologist. 2005; 11: 257–70
- Bensimon, G, Lacomblez, L, Meininger, V, the ALS/Riluzole Study Group. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med. 1994;330:585–91.
- Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. An outcome study of riluzole in amyotrophic lateral sclerosis: a population-based study in Ireland, 1996–2000. J Neurol. 2003; 250: 473–9
- Boylan KB. Amyotrophic Lateral Sclerosis. Neurology: basic and clinical neurosciences, Z Wszolek. Elsevier, New York 2007; 859–78
- Chio A, Mora G, Leone M, Mazzini L, Cocito D, Giordana MT, et al. Early symptom progression rate is related to ALS outcome: a prospective population-based study. Neurology. 2002; 59: 99–103
- Mazzini L, Corra T, Zaccala M, Mora G, Del Piano M, Galante M. Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol. 1995; 242: 695–8
- Radunovic A, Mitsumoto H, Leigh PN. Clinical care of patients with amyotrophic lateral sclerosis. Lancet Neurol. 2007; 6: 913–25
- Jenkinson C, Fitzpatrick R, Brennan C, Swash M. Evidence for the validity and reliability of the ALS assessment questionnaire: the ALSAQ-40. Amyotroph Lateral Scler Other Motor Neuron Disord. 1999; 1: 33–40
- Simmons Z, Felgoise SH, Bremer BA, Walsh SM, Bromberg MB, David W, et al. Development and validation of an ALS-specific quality of life instrument. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004; 5(Suppl 2)140
- Neudert C, Wasner M, Borasio GD. Patients’ assessment of quality of life instruments: a randomized study of SIP, SF-36 and SEIQoL-DW in patients with amyotrophic lateral sclerosis. J Neuro Sci. 2001; 191: 103–9
- Robbins RA, Simmons Z, Bremer BA, Walsh SM, Fischer S. Quality of life in ALS is maintained as physical function declines. Neurology. 2001; 56: 442–4
- Simmons Z, Bremer BA, Robbins RA, Walsh SM, Fischer S. Quality of life in ALS depends on factors other than strength and physical function. Neurology. 2000; 55: 388–92
- Gelinas DF, O'Connor P, Miller RG. Quality of life for ventilator-dependent ALS patients and their caregivers. J Neurol Sci. 1998; 160(Suppl 1)S134–6
- Kaub-Wittemer D, Von Steinbuchel N, Wasner M, Laier-Groenveld G, Borasio GD. Quality of life and psychosocial issues in ventilated patients with amyotrophic lateral sclerosis and their caregivers. J Pain Symptom Manage. 2003; 26: 890–6
- Goode RL, Smith RA. The surgical management of sialorrhea. Laryngoscope. 1970; 80: 1078–89
- Charchaflie FJ, Fernandez LB, Perec CJ, Gonzalez E, Marzi A. Functional studies of the parotid and pancreas glands in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1974; 37: 863–7
- Woodard TD, Oplatek A, Petruzzelli GJ. Life after total laryngectomy: a measure of long-term survival, function, and quality of life. Arch Otolaryngol Head Neck Surg. 2007; 133: 526–32
- Takano Y, Suga M, Sakamoto O, Sato K, Samejima Y, Ando M. Satisfaction of patients treated surgically for intractable aspiration. Chest. 1999; 116: 1251–6
- Olney RK, Murphy J, Forshew D, Garwood E, Miller BL, Langmore S, et al. The effects of executive and behavioral dysfunction on the course of ALS. Neurology. 2005; 65: 1774–7